Fertility preservation in Hodgkin’s lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era

References

• EngertADiehlVFranklinJEscalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin’s lymphoma: 10 years of follow-up of the GHSG HD9 studyJ Clin Oncol200927274548455419704068
   PubMed Web of Science ®Google Scholar
• DonatoEMFernandez-ZarzosoMDe La RubiaJImmunotherapy for the treatment of Hodgkin lymphomaExpert Rev Hematol201710541742328359170
   PubMed Web of Science ®Google Scholar
• PhillipsTMercerJSurveillance scans in lymphoma: friend or foe?Curr Treat Options Oncol20171821028214975
   PubMed Web of Science ®Google Scholar
• JohnsonPLongleyJShould response-adapted therapy now be the standard of care for advanced Hodgkin’s lymphoma?Curr Treat Options Oncol20171831528286922
   PubMed Web of Science ®Google Scholar
• BrammerJEKhouriIGaballaSOutcomes of haploidentical stem cell transplantation for lymphoma with melphalan-based conditioningBiol Blood Marrow Transplant201622349349826497906
   PubMedGoogle Scholar
• FeticaBAchimas-CadariuPPopBNon-Hodgkin lymphoma in Romania: a single-centre experienceHematol Oncol201735219820526482423
   PubMed Web of Science ®Google Scholar
• TomuleasaCAkin-AbayomiEDimaDDo lymphomas have an autoimmune background and how can we increase the sensitivity of the diagnosis of primary pancreatic lymphoma with relatively small samples?J Gastrointestin Liver Dis201524339139226405714
   PubMed Web of Science ®Google Scholar
• GrewalRCucuianuASwanepoelCThe role of microRNAs in the pathogenesis of HIV-related lymphomasCrit Rev Clin Lab Sci201552523224126218036
   PubMed Web of Science ®Google Scholar
• TanaseATomuleasaCMarculescuABardasAColitaACiureaSOFirst successful haploidentical stem cell transplantation in RomaniaRom J Intern Med201654319420027658169
   PubMedGoogle Scholar
• GiacconeLFestucciaMZallioFLong-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphomaBone Marrow Transplant20175281208121128581461
   PubMed Web of Science ®Google Scholar
• GaballaSGeIEl FakihRResults of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantationCancer2016122213316332627404668
   PubMed Web of Science ®Google Scholar
• TanaseATomuleasaCMarculescuAHaploidentical donors: can faster transplantation be life-saving for patients with advanced disease?Acta Haematol2016135421121626914538
   PubMed Web of Science ®Google Scholar
• AldeaMCraciunLTomuleasaCRepositioning metformin in cancer: genetics, drug targets, and new ways of deliveryTumour Biol20143565101511024504677
   PubMedGoogle Scholar
• GafencuGATomuleasaCIGhiaurGPARP inhibitors in acute myeloid leukaemia therapy: How a synthetic lethality approach can be a valid therapeutic alternativeMed Hypotheses2017104303428673584
   PubMed Web of Science ®Google Scholar
• Nagy-SimonTTatarASCraciunAMAntibody conjugated, raman tagged hollow gold-silver nanospheres for specific targeting and multimodal dark-field/SERS/two photon-FLIM imaging of CD19(+) B lymphoblastsACS Appl Mater Interfaces2017925211552116828574250
   PubMed Web of Science ®Google Scholar
• PetrushevBBocaSSimonTGold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapyInt J Nanomedicine20161164166026929621
   PubMed Web of Science ®Google Scholar
• AldeaMDPetrushevBSoritauOMetformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cellsJ BUON201419250251124965413
   PubMed Web of Science ®Google Scholar
• Lutchman SinghKDaviesMChatterjeeRFertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testingHum Reprod Update2005111698915569700
   PubMed Web of Science ®Google Scholar
• O’FlahertyCVaishevaFHalesBFChanPRobaireBCharacterization of sperm chromatin quality in testicular cancer and Hodgkin’s lymphoma patients prior to chemotherapyHum Reprod20082351044105218346994
   PubMed Web of Science ®Google Scholar
• FabbriRPasquinelliGMagnaniVFollicle features in adolescent and young adult women with Hodgkin’s disease prior to chemotherapy: a preliminary reportReprod Biomed Online201123679980522036188
   PubMed Web of Science ®Google Scholar
• PeccatoriFAAzimHAJrOrecchiaRCancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201324Suppl 6vi16017023813932
   PubMed Web of Science ®Google Scholar
• DimaDTomuleasaCFrincIThe use of rotation to fentanyl in cancer-related painJ Pain Res20171034134828223843
   PubMed Web of Science ®Google Scholar
• HuserMSmardovaLVentrubaPMayerJImpact of oncological treatment on human reproductionKlin Onkol201023316517020608326
   PubMedGoogle Scholar
• HuserMZakovaJSmardovaLCombination of fertility preservation strategies in young women with recently diagnosed cancerEur J Gynaecol Oncol2012331425022439404
   PubMed Web of Science ®Google Scholar
• VladCKubelacPOnisimAExpression of CDCP1 and ADAM12 in the ovarian cancer microenvironmentJ BUON201621497397827685922
   PubMed Web of Science ®Google Scholar
• BochisOVFeticaBVladCAchimas-CadariuPIrimieAThe importance of ubiquitin E3 ligases, SCF and APC/C, in human cancersClujul Med201588191426528041
   PubMedGoogle Scholar
• IrimieAIBraicuCPileczkiVKnocking down of p53 triggers apoptosis and autophagy, concomitantly with inhibition of migration on SSC-4 oral squamous carcinoma cellsMol Cell Biochem20164191–2758227370646
   PubMed Web of Science ®Google Scholar
• FrincIMuresanMSZaharieFCancer stem-like cells: the dark knights of clinical hematology and oncologyJ BUON201419232833524965388
   PubMed Web of Science ®Google Scholar
• HuQHongLNieMThe effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve womenJ Ovarian Res20171013228472976
   PubMedGoogle Scholar
• IrimieAAchimas-CadariuPBurzCPuscasEMultiple primary malignancies–epidemiological analysis at a single tertiary institutionJ Gastrointestin Liver Dis2010191697320361078
   PubMed Web of Science ®Google Scholar
• KubelacMPFeticaBVladICFulopAPopaAAchimas-CadariuPThe role of inhibitor of DNA-binding 1 (ID-1) protein and angiogenesis in serous ovarian cancerAnticancer Res201434141341624403496
   PubMedGoogle Scholar
• VladCKubelacPOnisimAIrimieAAchimas-CadariuPThe role of CDCP1 (CUB domain-containing protein 1) and ADAM12 (a disintegrin and metalloproteinase 12) in ovarian cancerJ BUON201520367367926214617
   PubMed Web of Science ®Google Scholar
• GhermanCBraicuOLZanoagaOCaffeic acid phenethyl ester activates pro-apoptotic and epithelial-mesenchymal transition-related genes in ovarian cancer cells A2780 and A2780cisMol Cell Biochem20164131–218919826838168
   PubMed Web of Science ®Google Scholar
• HaukvikUKDiesetIBjoroTHolteHFossaSDTreatment-related premature ovarian failure as a long-term complication after Hodgkin’s lymphomaAnn Oncol20061791428143316831852
   PubMed Web of Science ®Google Scholar
• ZhengYThomasASchmidtCMDannCTQuantitative detection of human spermatogonia for optimization of spermatogonial stem cell cultureHum Reprod201429112497251125267789
   PubMed Web of Science ®Google Scholar
• van der KaaijMAHeutteNvan Echten-ArendsJSperm quality before treatment in patients with early stage Hodgkin’s lymphoma enrolled in EORTC-GELA Lymphoma Group trialsHaematologica200994121691169719850901
   PubMed Web of Science ®Google Scholar
• AnselmoAPCartoniCBellantuonoPMaurizi-EnriciRAboulkairNErminiMRisk of infertility in patients with Hodgkin’s disease treated with ABVD vs MOPP vs ABVD/MOPPHaematologica19907521551581694156
   PubMed Web of Science ®Google Scholar
• BonfanteVSantoroAVivianiSValagussaPBonadonnaGABVD in the treatment of Hodgkin’s diseaseSemin Oncol1992192 Suppl 53844 discussion 44–45
   PubMedGoogle Scholar
• HodgsonDCPintilieMGittermanLFertility among female Hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapyHematol Oncol2007251111517036376
   PubMed Web of Science ®Google Scholar
• BrusamolinoEBaioAOrlandiELong-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin’s lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-upClin Cancer Res200612216487649317085663
   PubMed Web of Science ®Google Scholar
• BehringerKBreuerKReinekeTSecondary amenorrhea after Hodgkin’s lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin’s Lymphoma Study GroupJ Clin Oncol200523307555756416234521
   PubMed Web of Science ®Google Scholar
• DecanterCMorschhauserFPignyPLefebvreCGalloCDewaillyDAnti-Mullerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary resultsReprod Biomed Online201020228028520113967
   PubMed Web of Science ®Google Scholar
• YukselABildikGSenbabaogluFThe magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cellsHum Reprod201530122926293526466914
   PubMed Web of Science ®Google Scholar
• LambertiniMDel MastroLVigliettiGPondeNFSolinasCde AzambujaEOvarian function suppression in pemenopausal women with early-stage breast cancerCurr Treat Options Oncol2017181428185173
   PubMed Web of Science ®Google Scholar
• HarelSFermeCPoirotCManagement of fertility in patients treated for Hodgkin’s lymphomaHaematologica201196111692169921828120
   PubMed Web of Science ®Google Scholar
• LeroyCRigotJMLeroyMImmunosuppressive drugs and fertilityOrphanet J Rare Dis20151013626490561
   PubMed Web of Science ®Google Scholar
• LorenAWFertility issues in patients with hematologic malignanciesHematology Am Soc Hematol Educ Program2015201513814526637713
   PubMedGoogle Scholar
• AshPThe influence of radiation on fertility in manBr J Radiol1980536282712786991051
   PubMed Web of Science ®Google Scholar
• NakayamaKLiuPDetryMReceiving information on fertility- and menopause-related treatment effects among women who undergo hematopoietic stem cell transplantation: changes in perceived importance over timeBiol Blood Marrow Transplant200915111465147419822307
   PubMed Web of Science ®Google Scholar
• SwerdlowAJCookeRBatesARisk of premature menopause after treatment for Hodgkin’s lymphomaJ Natl Cancer Inst20141069
   Google Scholar
• de BruinMLHuisbrinkJHauptmannMTreatment-related risk factors for premature menopause following Hodgkin lymphomaBlood2008111110110817890454
   PubMed Web of Science ®Google Scholar
• KapkeJTEpperlaNShahNEffect of routine surveillance imaging on the outcomes of patients with classical Hodgkin lymphoma after autologous hematopoietic cell transplantationClin Lymphoma Myeloma Leuk201717740841428756899
   PubMed Web of Science ®Google Scholar
• WilkeCCaoQDusenberyKERole of consolidative radiation therapy after autologous hematopoietic cell transplantation for the treatment of relapsed or refractory Hodgkin lymphomaInt J Radiat Oncol Biol Phys20179919410228816170
   PubMed Web of Science ®Google Scholar
• PadbergSMickIFrenzelCGreilRHilberathJSchaeferCTransient congenital dilated cardiomyopathy after maternal R-CHOP chemotherapy during pregnancyReprod Toxicol20177114614928552383
   PubMed Web of Science ®Google Scholar
• BragnesYBoshuizenRde VriesALexbergAOstensenMLow level of Rituximab in human breast milk in a patient treated during lactationRheumatology20175661047104828339781
   PubMed Web of Science ®Google Scholar
• PrinceHMKimYHHorwitzSMBrentuximab vedotin or physician’s choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trialLancet20173901009455556628600132
   PubMed Web of Science ®Google Scholar
• BairSMStrelecLNagleSJOutcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: a retrospective analysisAm J Hematol201792987988428512788
   PubMed Web of Science ®Google Scholar
• GafencuGASeliceanSEPetrushevBClinicopathological analysis of a case series of peripheral T-cell lymphomas, not otherwise specified, of lymphoepithelioid variant (Lennert’s lymphoma). A Central European single-center studyHum Pathol20165319219427016488
   PubMed Web of Science ®Google Scholar
• DimaDTomuleasaCIrimieAMagnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximabCancer20141202440054006
   PubMed Web of Science ®Google Scholar
• AnsellSMBrentuximab vedotinBlood2014124223197320025293772
   PubMed Web of Science ®Google Scholar
• ScottLJBrentuximab vedotin: a review in CD30-positive Hodgkin lymphomaDrugs201777443544528190142
   PubMed Web of Science ®Google Scholar
• MoskowitzCHNademaneeAMassziTBrentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin’s lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trialLancet201538599801853186225796459
   PubMed Web of Science ®Google Scholar
• KanematsuDShofudaTYamamotoAIsolation and cellular properties of mesenchymal cells derived from the decidua of human term placentaDifferentiation2011822778821684674
   PubMed Web of Science ®Google Scholar
• OnisimAAchimas-CadariuAVladCKubelacPAchimas-CadariuPCurrent insights into the association of Nestin with tumor angiogenesisJ BUON201520369970626214620
   PubMed Web of Science ®Google Scholar
• FlerlageJEMetzgerMLWuJPanettaJCPharmacokinetics, immunogenicity, and safety of weekly dosing of brentuximab vedotin in pediatric patients with Hodgkin lymphomaCancer Chemother Pharmacol20167861217122327837256
   PubMed Web of Science ®Google Scholar
• AnsellSMNivolumab in the treatment of Hodgkin lymphomaClin Cancer Res20172371623162627881581
   PubMed Web of Science ®Google Scholar
• LesokhinAMAnsellSMArmandPNivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a phase Ib studyJ Clin Oncol201634232698270427269947
   PubMed Web of Science ®Google Scholar
• MerrymanRWKimHTZinzaniPLSafety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphomaBlood2017129101380138828073785
   PubMed Web of Science ®Google Scholar
• LinRJDiefenbachCSCheckpoint inhibition in Hodgkin lymphoma: saving the best for last?Oncology (Williston Park)2016301091492027753058
   PubMed Web of Science ®Google Scholar
• Pembrolizumab approved for Hodgkin lymphomaCancer Discov201775OF1
   Google Scholar
• ChenRZinzaniPLFanaleMAPhase II study of the efficacy and safety of pembrolizumab for relapsed/refractory classic Hodgkin lymphomaJ Clin Oncol201735192125213228441111
   PubMed Web of Science ®Google Scholar
• ArmandPShippMARibragVProgrammed death-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failureJ Clin Oncol201634313733373927354476
   PubMed Web of Science ®Google Scholar
• EllingerIFuchsRHFcRn-mediated transplacental immunoglobulin G transport: protection of and threat to the human fetus and newbornWien Med Wochenschr20121629–1020721322717875
   PubMedGoogle Scholar
• WarringtonJPDrummondHAGrangerJPRyanMJPlacental ischemia-induced increases in brain water content and cerebrovascular permeability: role of TNF-αAm J Physiol Regul Integr Comp Physiol201530911R1425143126400187
   PubMed Web of Science ®Google Scholar
• PfreundschuhMGerman High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)High-dose chemotherapy and autologous stem-cell transplantation for DLBCL in the rituximab eraLancet Oncol201718898999128759369
   PubMed Web of Science ®Google Scholar
• Della PepaRPicardiMGiordanoCRituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphomaBr J Haematol2017 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• TomuleasaCBraicuCIrimieACraciunLBerindan-NeagoeINanopharmacology in translational hematology and oncologyInt J Nanomedicine201493465347925092977
   PubMed Web of Science ®Google Scholar
• ChakravartyEFMurrayERKelmanAFarmerPPregnancy outcomes after maternal exposure to rituximabBlood201111751499150621098742
   PubMed Web of Science ®Google Scholar
• ThurnLLindqvistPGJakobssonMAbstracts of the 26th World Congress on Ultrasound in Obstetrics and Gynecology, Rome, Italy, 24–28 September 2016Ultrasound Obstet Gynecol201648Suppl 1140
   Google Scholar
• BroerSLBroekmansFJLavenJSFauserBCAnti-Mullerian hormone: ovarian reserve testing and its potential clinical implicationsHum Reprod Update201420568870124821925
   PubMed Web of Science ®Google Scholar
• GultekinMDursunPVranesBGynecologic oncology training systems in Europe: a report from the European network of young gynaecological oncologistsInt J Gynecol Cancer20112181500150621720256
   PubMed Web of Science ®Google Scholar
• OrdeanuCPopDCBadeaRLocal experience in cervical cancer imaging: Comparison in tumour assessment between TRUS and MRIRep Pract Oncol Radiother201520322323025949227
   PubMedGoogle Scholar
• MahanyEBRandolphJFJrBiochemical and imaging diagnostics in endocrinology: predictors of fertilityEndocrinol Metab Clinics North Am2017463679689
   PubMed Web of Science ®Google Scholar
• IrahaYOkadaMIrahaRCT and MR imaging of gynecologic emergenciesRadiographics20173751569158628753380
   PubMed Web of Science ®Google Scholar
• LambertiniMCinquiniMMoschettiITemporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical OncologyEur J Cancer201771253327940355
   PubMed Web of Science ®Google Scholar
• BedaiwyMAAllaireCAlfarajSLong-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapyFertil Steril2017107353754828139239
   PubMed Web of Science ®Google Scholar
• HuserMSmardovaLJankuPFertility status of Hodgkin lymphoma patients treated with chemotherapy and adjuvant gonadotropin-releasing hormone analoguesJ Assist Reprod Genet20153281187119325724588
   PubMed Web of Science ®Google Scholar
• FalorioSAngrilliFFioritoniGGonadotropin-releasing hormone analog treatment for the prevention of treatment-related ovarian failure and infertility in women of reproductive age with Hodgkin lymphomaLeuk Lymphoma20084961087109318452079
   PubMed Web of Science ®Google Scholar
• BlumenfeldZAviviIEckmanAEpelbaumRRoweJMDannEJGonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphomaFertil Steril200889116617317601603
   PubMed Web of Science ®Google Scholar
• NitzschkeMRaddatzJBohlmannMKStutePStrowitzkiTvon WolffMGnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin’s lymphoma patientsArch Gynecol Obstet20102821838819967405
   PubMed Web of Science ®Google Scholar
• BehringerKWildtLMuellerHNo protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study GroupAnn Oncol201021102052206020305034
   PubMed Web of Science ®Google Scholar
• SonigoCSerokaACedrin-DurnerinISermondadeNSiferCGrynbergMHistory of ABVD alters the number of oocytes vitrified after in vitro maturation in fertility preservation candidatesFuture Oncol201612141713171926960957
   PubMed Web of Science ®Google Scholar
• AlvarezRMRamanathanPFertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation responseHum Reprod2016pii dew158. [Epub ahead of print]
   Web of Science ®Google Scholar
• DahhanTBalkenendeEMEBeerendonkCCMStimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trialContemp Clin Trials2017619610028710053
   PubMed Web of Science ®Google Scholar
• PereiraNHubschmannAGLekovichJPSchattmanGLRosenwaksZEx vivo retrieval and cryopreservation of oocytes from oophorectomized specimens for fertility preservation in a BRCA1 mutation carrier with ovarian cancerFertil Steril2017108235736028629583
   PubMed Web of Science ®Google Scholar
• RienziLCoboAPaffoniAConsistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric studyHum Reprod20122761606161222442248
   PubMed Web of Science ®Google Scholar
• DonnezJMartinez-MadridBJadoulPVan LangendoncktADemylleDDolmansMMOvarian tissue cryopreservation and transplantation: a reviewHum Reprod Update200612551953516849817
   PubMed Web of Science ®Google Scholar
• BineshFAkhavanABehniafardNAtefiAClinicopathologic and survival characteristics of childhood and adolescent non Hodgkin’s lymphoma in Yazd, IranAsian Pac J Cancer Prev20141541585158824641372
   PubMedGoogle Scholar
• AnselmoAPCavalieriEAragonaCSbraciaMFunaroDMaurizi EnriciRSuccessful pregnancies following an egg donation program in women with previously treated Hodgkin’s diseaseHaematologica200186662462811418371
   PubMed Web of Science ®Google Scholar
• EvensonDPJostLKMarshallDUtility of the sperm chromatin structure assay as a diagnostic and prognostic tool in the human fertility clinicHum Reprod199914410394910221239
   PubMed Web of Science ®Google Scholar
• SergerieMLaforestGBujanLBissonnetteFBleauGSperm DNA fragmentation: threshold value in male fertilityHum Reprod200520123446345116085665
   PubMed Web of Science ®Google Scholar
• MorrisIDIlottSDixonLBrisonDRThe spectrum of DNA damage in human sperm assessed by single cell gel electrophoresis (Comet assay) and its relationship to fertilization and embryo developmentHum Reprod200217499099811925396
   PubMed Web of Science ®Google Scholar
• ZubkovaEVWadeMRobaireBChanges in spermatozoal chromatin packaging and susceptibility to oxidative challenge during agingFertil Steril200584Suppl 21191119816210011
   PubMedGoogle Scholar
• RedigAJBranniganRStrykerSJWoodruffTKJerussJSIncorporating fertility preservation into the care of young oncology patientsCancer2011117141021235031
   PubMed Web of Science ®Google Scholar
• HowellSJShaletSMSpermatogenesis after cancer treatment: damage and recoveryJ Natl Cancer Inst Monogr2005341217
   PubMedGoogle Scholar
• SieniawskiMReinekeTJostingAAssessment of male fertility in patients with Hodgkin’s lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trialsAnn Oncol200819101795180118544558
   PubMed Web of Science ®Google Scholar
• LorenAWManguPBBeckLNFertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline updateJ Clin Oncol201331192500251023715580
   PubMed Web of Science ®Google Scholar
• SucalaMCuijpersPMuenchFAnxiety: there is an app for that. A systematic review of anxiety appsDepress Anxiety201734651852528504859
   PubMed Web of Science ®Google Scholar
• TomuleasaCZaharieFMuresanMSHow to diagnose and treat a cancer of unknown primary siteJ Gastrointest Liver Dis20172616979
   PubMed Web of Science ®Google Scholar
• BraicuCChioreanRIrimieANovel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapyExpert Rev Mol Med201618e1827817751
   PubMed Web of Science ®Google Scholar
• FrincIIliesPZaharieFTransthoracic ultrasonography for the immunocompromised patient. A pilot project that introduces trans-thoracic ultrasonography for the follow-up of hematological patients in RomaniaRom J Intern Med201755210311628103204
   PubMedGoogle Scholar
• MicuRPetrutBZlatescu-MartonCTrailaAHarsaRAchimas-CadariuPCurrent strategies and future perspectives in fertility preservation for cancer patientsJ BUON201722484485229155509
   PubMed Web of Science ®Google Scholar
• TrutaZGarlovanuMLerintiuSMicuRA new method for human semen glucose concentration evaluationRom Biotech Lett20101557645772
   Web of Science ®Google Scholar